NovaBridge Biosciences
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $970.7M
Liabilities Breakdown FY2020
Total Liabilities: $108.3M
Asset Breakdown
Total Assets: $970.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $729.3M | 75.1% |
| Accounts Receivable | $20.0M | 2.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.9M | 0.4% |
| Goodwill | $24.9M | 2.6% |
| Intangible Assets | $18.5M | 1.9% |
| Other Assets | $174.1M | 17.9% |
Liabilities Breakdown
Total Liabilities: $108.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $108.3M | 100.0% |